Key result
Longer hypertension duration is linked to ~6% higher risk of nonfatal cardiovascular events.
Why the study?
The study aimed to evaluate the impact of hypertension burden on the development of nonfatal cardiovascular events in patients with atherosclerosis-associated pathology.
Does the cumulative burden of hypertension (disease duration and left ventricular mass index) predict the development of nonfatal cardiovascular events in patients with atherosclerosis-associated pathology?
Cohort (n=431)
Does the cumulative burden of hypertension (disease duration and left ventricular mass index) predict the development of nonfatal cardiovascular events in patients with atherosclerosis-associated pathology?
Answers are grounded in this paper and cite their sources.
Cumulative hypertension burden—specifically disease duration and quantitative left ventricular mass index—has greater prognostic value for nonfatal cardiovascular events than current office blood pressure control alone.
Objective. To evaluate the impact of hypertension burden on the development of nonfatal cardiovascular events. Materials and methods. A retrospective study of electronic medical records of 431 cardiology patients was conducted. The exclusion criterion was a history of nonfatal cardiovascular events at the time of the first visit. Patients were divided into two groups: those without cardiovascular events (n = 336) and those with nonfatal complications recorded by the second visit (n = 95). Results. At the initial visit, despite comparable office systolic and diastolic blood pressure levels between the groups (p > 0.05), patients with subsequent cardiovascular events (CVE) more frequently had hypertension (86.3% vs. 68.8%, p < 0.001), left ventricular hypertrophy (LVH) (57.9% vs. 39.3%, p = 0.001), and diastolic dysfunction (DD) (43.2% vs. 27.4%, p < 0.001). According to binary logistic regression, the statistically significant independent predictors of CVE were the duration of hypertension (OR = 1.057; 95% CI: 1.005–1.112; p = 0.030) and left ventricular mass index (LVMI) (OR = 1.019; 95% CI: 1.004–1.034; p = 0.011), whereas the binary indicator of LVH and the type of DD did not reach significance in the multivariate model. Achieving target blood pressure values at the follow-up visit did not prevent events in the presence of accumulated structural left ventricular damage, as confirmed by the persistently higher LVMI in the CVE group (111.0 vs. 102.0 g/m2 in those without events) despite effective blood pressure reduction. Conclusion. The cumulative burden of hypertension, reflected in disease duration and the quantitative extent of left ventricular hypertrophy (LVMI), has greater prognostic value than current office hemodynamic parameters. Our findings support the need for cardiovascular risk stratification that necessarily incorporates the degree of myocardial remodeling, rather than relying solely on the achievement of target blood pressure levels.
No takes yet. Share an insight, caveat, or question.
Bakulin et al. (2026) conducted a cohort in Atherosclerosis-associated pathology (n=431). Cumulative hypertension burden (duration of hypertension and left ventricular mass index) vs. Absence of subsequent nonfatal cardiovascular events was evaluated on Nonfatal cardiovascular events recorded by the second visit (OR 1.057, 95% CI 1.005-1.112, p=0.030). Duration of hypertension and LV mass index independently predicted nonfatal cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: